LCBI Awards Its First Low-Carbon Labels in Germany and Belgium to The Stack in Munich and Luxia in Brussels
8.9.2025 14:42:00 CEST | Business Wire | Press Release
The Low Carbon Building Initiative (LCBI), launched in 2022 by major European real estate players and BBCA (the Association for the Development of Low Carbon Buildings), presents two new international labels in Brussels and in Munich at SIBCA, the low-carbon real estate trade fair, which took place from 3rd to 5th September in Paris.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908685544/en/
The Stack, timber offices in Munich
The Stack, timber offices in Munich
AXA IM Alts launched the construction of ‘The Stack,’ a c. 17,100 sqm timber hybrid office asset in the centre of Munich. The scheme, designed by Wilmotte & Associés Architectes and implemented by RKW Architektur +, aims to achieve market-leading environmental credentials, combining a sustainably sourced timber-hybrid construction method with green energy technology and biophilic design features.
Overall, the strategy has allowed to drastically reduce the project’s carbon footprint compared to a typical new-build development, reaching the ”Excellent” level of LCBI label at design stage.
Low-carbon construction materials were used with approx. 1,800 cubic meters of spruce wood from Austria, with an amount of 325.5 kg CO2e/m² embodied carbon (30% less than DGNB-certified solid construction).
The building is also supplied with district cooling and heating from Munich's municipal utilities and uses the best technologies, reaching 8.27 kg CO2e/m² in Operational Carbon, i.e. 40% less compared to the DGNB benchmark.
Advanced smart building technology, including CO₂ sensors, variable ventilation systems and intelligent lighting controls, regulates indoor air quality and supports enhanced workplace productivity and wellbeing.
Luxia, low carbon offices connected to Brussels city center
Luxia is a prime, low-carbon office building developed by AXA IM Alts. Designed by the Brussels-based architects DDS+, the recently delivered state-of-the-art 13.000 sqm (GFA) building has been developed in line with circularity principles. Luxia is built on preserved foundations and re-uses many materials and the concrete of the demolished building, allowing for a drastic reduction in carbon footprint of its construction phase.
Conceived as a pioneering low-carbon project, Luxia is the first project to receive the LCBI Certificate in Belgium, reaching the LCBI Performance level at delivery. Having achieved the highest possible score on all ESG-performance metrics, it is recognized as one of the most sustainable buildings in Brussels, certified as BREEAM Outstanding, WELL Gold, PEB A, Airscore A, Wiredscore Gold, and the labels Fossil-Free and Biodiversity.
With the ambition to minimize the overall carbon footprint of the project, Luxia has managed to reduce Co2 emissions on all phases of the building’s life cycle. The carbon footprint of the construction phase, measured on full scope, is limited to 931 kgCO2e/m² (50yr) and the annual operational carbon to a very low 11,2 kgCO2e/m². The energy consumption has been drastically lowered to 48 kWh/m²/year, by using heat pumps, solar energy and a comprehensive smart building approach.
“The Luxia project benefits from a strong location and is positioned as a high-quality product on the Brussels market, with large outdoor terraces, low energy consumption and a wide range of first-rate business services. Luxia is a Green Trophy Asset for our client, and will, as a future proof building, fully contribute to our ambitious ESG-strategy. The LCBI-certification process enabled us to keep a 360° view as from the design phase. Also, it allowed us to maintain a coherent grasp of the interests of our client, the end-user and for the future of the asset.”
— Marc Kramer, Head of Development Benelux, AXA IM Alts
“The Stack offers the opportunity to meet demand for high-end, ESG-oriented, well-connected office space in downtown Munich, just two minutes from the central station. With delivery scheduled for early 2026, the pre-lease rate of around 60% reflects the appeal of our flexible and collaborative office concept, which is attracting forward-thinking users. As the first LCBI-certified office building in Germany, this project affirms our commitment to sustainability and has been designed to meet the evolving needs of demanding tenants and align with our global investment principles."
— Filipe de Sá Pessoa, Head of Development Germany, AXA IM Alts
“We are delighted to award two new certifications in Brussels and in Munich, extending the LCBI footprint already established in Milan, Paris and Belval (Luxemburg). We are showing that the progress of real estate decarbonization in Europe relies on close collaboration with local stakeholders, at each step of a building project. We are proud that our technical expertise is sufficiently well-recognized in Europe to attract the interest of major players in the real estate sector such as AXA IM Alts. It is a matter of considerable pride for us to see that these companies have demonstrated their commitment to decarbonization and their confidence in our technology.”
— Cécile DAP, LCBI Director
... Some figures from BBCA, the association behind the LCBI initiative, revealed at SIBCA on the same day in France:
- In 2025, 2.25 million m² were committed to or certified by BBCA (compared to 1.55 million in 2024 and 1.48 million in 2023). New builds account for 43% of production.
- In just one year, BBCA has certified nearly 700,000 m², an increase of nearly 100% compared to 2024.
- Since 2016, BBCA applications in progress or certifications have exceeded 5.7 million m² (compared to 4.55 million in 2024), corresponding to 760 projects in 2025 (compared to 630 in 2024).
About LCBI
The Low Carbon Building Initiative was launched in 2022 by major players in the real estate sector (Generali Real Estate, Covivio, BPI Real Estate, BNP Paribas Real Estate, Bouygues Immobilier, WO2, Icamap, NSI, Ivanhoé Cambridge and AXA IM Alts) and BBCA (the Association for the Development of Low-Carbon Buildings). Its aim is to develop the low-carbon certification of real estate projects in Europe in order to hasten the decarbonisation of the sector. Based on key European standards and benchmarks, the LCBI methodology serves to standardise the practice of life-cycle analysis (ACV) throughout Europe. The LCBI label, audited by Bureau Veritas and CERTIVEA, takes account of the complete life cycle of buildings, and measures the carbon footprint as well as the comprehensiveness of the ACV on three levels: grey carbon (emissions associated with construction) measured in kgCO2e/sq.m over 50 ans, carbon from use (linked to consumption and energy sources) measured in kgCO2e/sq.m./year, and the measurement of biogenic carbon storage contained in the building measured in kgCO2e/sq.m. The label has three performance levels: Standard, Performance and Excellence.
https://www.lowcarbonbuilding.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250908685544/en/
Contacts
PRESS
LES ROIS MAGES | clemence.mayrand-freynet@lesroismages.fr (+33 6 28 04 21 98)
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom